Clinical evaluation of medicinal products intended for treatment of hepatitis B

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/6172/2003
Effective from01/09/2006
KeywordsHepatitis B, diagnostic criteria, non-inferiority trials, superiority trials, endpoints, comparator, special populations, safety evaluation
DescriptionThis document provides guidance on the clinical evaluation of new medicinal products in the treatment of chronic hepatitis B.

Related content

How helpful is this page?

Average rating:

 Based on 20 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
4 ratings

Tell us more